Communicate with your clients in their language


Client Portal

what we do

KONTEKST is a certified provider of translation services.

KONTEKST is a certified provider of translation services for global clinical research organizations, pharmaceutical companies, as well as law and consulting firms.

KONTEKST has been in existence since 2000, and specializes in translation services for contract research organizations (CROs), pharmaceutical companies, law firms, and consulting companies. We work with our Clients on a global level and we are among Approved Vendors for major global pharma companies. KONTEKST has the necessary tools and the know-how based on our 20+ years of expertise.

On 24 May 2019

KONTEKST successfully passed an audit by Bureau Veritas Certification Polska for compliance with the industry standard ISO 17100:2015.

The international standard ISO 17100 is a quality standard which replaces the previous European standard PN-EN 15038 in providing detailed specifications for the translation industry.

The standard describes the processes, definitions and requirements for quality translation and localisation services and translation project management.

Global Pharma & CRO
We don't have the time or the resources for in-house quality control, which is why we especially appreciate KONTEKST's experience and know-how in the field of clinical research. We don’t want to work with anyone else!
Spot Buyer for Poland and Baltics / Global Pharma & CRO
Global CRO
It is easier for us to meet the regulators' strict submission deadlines thanks to KONTEKST’s short response times and very efficient project implementation.
Start-up Director / Global CRO
Global Biotech
A key project enabling us to enter the European market was completed faster thanks to KONTEKST, who provided us with translations into all European languages.
Regulatory Affairs Manager / Global Biotech

KONTEKST in numbers

  • 250
    language combinations
  • 8 of 10
    largest Clinical Research Organizations are our clients
  • 300
    pharmaceutical clients
  • 0.4%
    complaint level
  • 40
    in-house team
European Medicines Regulatory Framework

European Medicines Regulatory Framework

The European Medicines Regulatory Network has adopted a Common Standard for the electronic product information (ePI) on medicines in the European Union (EU). The product information (PI) of a medicine includes the package leaflet for patients and the summary of...

read more
RARE DISEASES – a challenge for clinical research

RARE DISEASES – a challenge for clinical research

Even though names such as cystic fibrosis, Huntington's disease, hemophilia, retinoblastoma or amyotrophic lateral sclerosis often come up in medical shows, in real life they fall in the category of rare diseases. In the European Union, a disease is defined as rare if...

read more